Jane Street
CRDF icon

Jane Street’s Cardiff Oncology CRDF Stock Holding History

Jane Street’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105K Buy
+81,000
New +$129K ﹤0.01% 10562
2025
Q4 		– Sell
-22,300
Closed -$45.9K – 11292
2025
Q3 		$45.9K Buy
+22,300
New +$61.6K ﹤0.01% 10374
2025
Q1 		– Sell
-49,900
Closed -$217K – 9575
2024
Q4 		$217K Buy
+49,900
New +$156K ﹤0.01% 8290
2024
Q3 		– Sell
-10,700
Closed -$23.8K – 9659
2024
Q2 		$23.8K Sell
10,700
-17,100
-62% -$64.4K ﹤0.01% 9027
2024
Q1 		$148K Buy
+27,800
New +$73.9K ﹤0.01% 8351
2022
Q2 		– Sell
-12,100
Closed -$30K – 9774
2022
Q1 		$30K Sell
12,100
-13,700
-53% -$48.5K ﹤0.01% 9826
2021
Q4 		$155K Sell
25,800
-58,000
-69% -$346K ﹤0.01% 8980
2021
Q3 		$558K Buy
83,800
+18,400
+28% +$116K ﹤0.01% 7080
2021
Q2 		$435K Sell
65,400
-14,200
-18% -$120K ﹤0.01% 7499
2021
Q1 		$737K Sell
79,600
-400
-0.5% -$4.86K ﹤0.01% 6063
2020
Q4 		$1.44M Buy
80,000
+4,300
+6% +$75.6K ﹤0.01% 4068
2020
Q3 		$1.07M Buy
+75,700
New +$500K ﹤0.01% 3983

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jane Street's CRDF Position: Q2 2026 in Review

Jane Street increased its Cardiff Oncology (CRDF) stake by 1,416% in Q2 2026, buying an estimated $901K and bringing the position to 607,900 shares worth $790K. The position accounts for ﹤0.01% of the portfolio, ranked #7026.

Jane Street first reported a position in CRDF in Q4 2016 and has held it in 15 quarters since. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Jane Street held 607,900 shares of Cardiff Oncology worth $790K as of Q2 2026.
  • Jane Street bought 567,795 Cardiff Oncology shares in Q2 2026, an estimated $901K.
  • Cardiff Oncology made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #7026 holding.
  • Jane Street first reported a position in Cardiff Oncology in Q4 2016 and has held it in 15 quarters since.
  • 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.